EP 1722775 A1 20061122 - USE OF BETA-LAPACHONE FOR TREATING HEMATOLOGIC TUMORS
Title (en)
USE OF BETA-LAPACHONE FOR TREATING HEMATOLOGIC TUMORS
Title (de)
VERWENDUNG VON BETA-LAPACHON ZUR BEHANDLUNG VON HÄMATOLOGISCHEN TUMOREN
Title (fr)
UTILISATION DE BETA-LAPACHONE POUR TRAITER DES TUMEURS HEMATOLOGIQUES
Publication
Application
Priority
- US 2005005646 W 20050218
- US 54591504 P 20040220
Abstract (en)
[origin: WO2005082356A2] The present invention provides for methods that utilize agents effective in the treatment of a wide range of cancerous and pre-cancerous conditions. Moreover, the present invention provides agents capable of acting as an inhibitor of cell proliferation in a broad range of cell types.
IPC 8 full level
A61K 31/352 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)
CPC (source: EP)
A61K 31/352 (2013.01); A61P 11/00 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 35/04 (2017.12)
Citation (search report)
See references of WO 2005082357A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005082356 A2 20050909; WO 2005082356 A3 20051027; WO 2005082356 A8 20060608; CA 2556823 A1 20050909; EP 1722775 A1 20061122; EP 1729760 A2 20061213; EP 2033640 A2 20090311; JP 2007523190 A 20070816
DOCDB simple family (application)
US 2005005645 W 20050218; CA 2556823 A 20050218; EP 05723506 A 20050218; EP 05723507 A 20050218; EP 08164583 A 20050218; JP 2006554302 A 20050218